Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study

Annals of Oncology

Volumn 9, Issue 6, 1998, Pages 661-666

  Goedhals, L ^a   Heron, J F ^b   Kleisbauer, J P ^c   Pagani, O ^d   Sessa, C ^d  

^a National Hospital Bloemfontein   (South Africa)

^b CENTRE FRANÇOIS BACLESSE   (France)

^c HÔPITAL SAINTE MARGUERITE   (France)

^d OSPEDALE SAN GIOVANNI   (Switzerland)

Author keywords

5 HT3 receptor antagonist; Cisplatin; Delayed emesis; Dexamethasone; Granisetran; Oral antiemetic

Indexed keywords

CISPLATIN; DEXAMETHASONE; GRANISETRON; ONDANSETRON;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASTHENIA; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; CYTOSTASIS; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; HEADACHE; HICCUP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CISPLATIN; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GRANISETRON; HUMANS; MALE; MIDDLE AGED; NAUSEA; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; SEROTONIN ANTAGONISTS; TIME FACTORS; TREATMENT OUTCOME; VOMITING;

EID: 0031820913     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008256115221     Document Type: Article

References (28)

1. Grunberg SM. Potential for combination therapy with the new antiserotonergic agents. Eur J Cancer 1993; 29A (Suppl 1): S39-41.
2. Marty M. the Granisetron Study Group. A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesis. Eur J Cancer 1992; 28A (Suppl 1): S12 6.
3. Chevallier B, the Granisetron Study Group. The control of acute cisplatin-induced emesis a comparative study of granisetron and a combination of high-dose metoclopramide and dexamethasone. Br J Cancer 1993; 68: 176 80.
4. De Mulder PHM, Seynaeve C, Vermorken JB et al. Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. Ann Intern Med 1990; 113: 834-40.
5. De Bruijn KM. Tropisetron. a review of the clinical experience. Drugs 1992; 43 (Suppl 3): 11 22.
6. 3 antagonist, versus a standard antiemetic regimen of dexamethasone and metoclopramide in the treatment of cisplatin-containing chemotherapy. Drug Invest 1993; 6: 162 9.
7. Schmoll H-J. The role of ondansetron in the treatment of emesis induced by non-cisplatin-containing chemotherapy regimes. Eur J Cancer 1989; 25 (Suppl 1): S35 9.
8. Bonneterre J, Chevallier B, Metz R et al. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide. fluorouracil. and doxorubicin or epirubicin chemotherapy. J Clin Oncol 1990; 8: 1063 9.
9. Portuguese Ondansetron Study Group. Ondansetron in the treatment of nausea and vomiting induced by chemotherapy. Anticancer Drugs 1993; 4 (Suppl 2): 23 7.
10. Jantunen IT, Flander M. Heikkinen MI et al. Comparison of ondansetron with customary treatment in the prophylaxis of nausea and emesis induced by non-cisplatin containing chemotherapy. Acta Oncol 1993; 32: 413 5.
11. Jones AL, Hill AS. Soukop M et al. Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 1991; 338: 483-7.
12. Rosso R, Campora E. Cetto G et al. Oral ondansetron (GR 38032F) for the control of acute and delayed cyclophosphamide-induced emesis. Anticancer Res 1991; 11: 937-40.
13. Smyth JF, Coleman RE, Nicolson M et al. Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron? BMJ 1991; 303: 1423 6.
14. Gandara DR, Harvey WH. Monaghan GG et al. The delayedemesis syndrome from cisplatin: Phase III evaluation of ondansetron versus placebo. Semin Oncol 1992; 19 (Suppl 10): 67 71.
15. Gandara DR. Progress in the control of acute and delayed emesis induced by cisplatin. Eur J Cancer 1991; 27 (Suppl 1):S9 11.
16. Roila F, Bracarda S, Tonato M et al. Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesis. Clin Oncol 1990; 2: 268 72.
17. Carmichael J, Bessel EM, Harris AL et al. Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis. Br J Cancer 1994; 70: 1161-4.
18. Kris MG, Gralla RJ, Tyson LB et al. Controlling delayed vomiting: Double-blind, randomized trial comparing placebo. dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 1989; 7: 108 14.
19. Coates A, Abraham S, Kaye SB et al. On the receiving end patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983; 19:203-8.
20. Del Favero A, Roila F, Tonato M. Reducing chemotherapy-induced nausea and vomiting. Current perspective and future possibilities. Drug Saf 1993; 9: 410 28.
21. Kris MG, Tyson LB, Clark A et al. Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and review of completed trials to manage delayed emesis. Cancer 1992; 70 (Suppl): 1012 6.
22. Bleiberg HH, Spielmann M, Falkson G et al. Anli-emetic treatment with oral granisetron in patients receiving moderately emetogenic chemotherapy: A dose-ranging study. Clin Ther 1995; 17: 38 51.
23. Johnston D, Latreille J, Laberge F et al. Preventing nausea and vomiting during days 2 7 following high dose cisplatin chemotherapy (HDCP). A study by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG). Proc Am Soc Clin Oncol 1995; 14: 529.
24. Heron JF, Goedhals L, Jordaan JP et al. Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. Ann Oncol 1994; 5: 579 84.
25. Roila F, Boschetti E, Tonato M et al. Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. Am J Clin Oncol (CCT) 1991; 14:238-42.
26. Louvet C. Lorange A. Letendre F et al. Acute and delayed emesis after cisplatin-based regimen: Description and prevention. Oncology 1991; 48: 392 6.
27. Italian Group for Antiemetic Research. Cisplatin-induced delayed emesis: Prognostic factors during three subsequent cycles. Ann Oncol 1994; 5: 585 9.
28. Du Bois A, Meerpohl HG, Vach W et al. Course, patterns, and risk-factors for chemotherapy-induced emesis in cisplatin-pretreated patients: A study with ondansetron. Eur J Cancer 1992; 28: 450 7.